1 Market Overview of Treatment for Syndromes of Dementia and Movement Disorders 1.1 Treatment for Syndromes of Dementia and Movement Disorders Market Overview 1.1.1 Treatment for Syndromes of Dementia and Movement Disorders Product Scope 1.1.2 Treatment for Syndromes of Dementia and Movement Disorders Market Status and Outlook 1.2 Global Treatment for Syndromes of Dementia and Movement Disorders Market Size Overview by Region 2016 VS 2021VS 2027 1.3 Global Treatment for Syndromes of Dementia and Movement Disorders Market Size by Region (2016-2027) 1.4 Global Treatment for Syndromes of Dementia and Movement Disorders Historic Market Size by Region (2016-2021) 1.5 Global Treatment for Syndromes of Dementia and Movement Disorders Market Size Forecast by Region (2022-2027) 1.6 Key Regions, Treatment for Syndromes of Dementia and Movement Disorders Market Size (2016-2027) 1.6.1 North America Treatment for Syndromes of Dementia and Movement Disorders Market Size (2016-2027) 1.6.2 Europe Treatment for Syndromes of Dementia and Movement Disorders Market Size (2016-2027) 1.6.3 Asia-Pacific Treatment for Syndromes of Dementia and Movement Disorders Market Size (2016-2027) 1.6.4 Latin America Treatment for Syndromes of Dementia and Movement Disorders Market Size (2016-2027) 1.6.5 Middle East & Africa Treatment for Syndromes of Dementia and Movement Disorders Market Size (2016-2027) 2 Treatment for Syndromes of Dementia and Movement Disorders Market Overview by Type 2.1 Global Treatment for Syndromes of Dementia and Movement Disorders Market Size by Type: 2016 VS 2021 VS 2027 2.2 Global Treatment for Syndromes of Dementia and Movement Disorders Historic Market Size by Type (2016-2021) 2.3 Global Treatment for Syndromes of Dementia and Movement Disorders Forecasted Market Size by Type (2022-2027) 2.4 Movement Disorders 2.5 Progressive Dementia 2.6 Progressive Dementia with Neurological Abnormality (PDNA) 3 Treatment for Syndromes of Dementia and Movement Disorders Market Overview by Application 3.1 Global Treatment for Syndromes of Dementia and Movement Disorders Market Size by Application: 2016 VS 2021 VS 2027 3.2 Global Treatment for Syndromes of Dementia and Movement Disorders Historic Market Size by Application (2016-2021) 3.3 Global Treatment for Syndromes of Dementia and Movement Disorders Forecasted Market Size by Application (2022-2027) 3.4 Below 70 Years 3.5 Above 70 Years 4 Treatment for Syndromes of Dementia and Movement Disorders Competition Analysis by Players 4.1 Global Treatment for Syndromes of Dementia and Movement Disorders Market Size by Players (2016-2021) 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Treatment for Syndromes of Dementia and Movement Disorders as of 2020) 4.3 Date of Key Players Enter into Treatment for Syndromes of Dementia and Movement Disorders Market 4.4 Global Top Players Treatment for Syndromes of Dementia and Movement Disorders Headquarters and Area Served 4.5 Key Players Treatment for Syndromes of Dementia and Movement Disorders Product Solution and Service 4.6 Competitive Status 4.6.1 Treatment for Syndromes of Dementia and Movement Disorders Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Valeant Pharmaceutical International 5.1.1 Valeant Pharmaceutical International Profile 5.1.2 Valeant Pharmaceutical International Main Business 5.1.3 Valeant Pharmaceutical International Treatment for Syndromes of Dementia and Movement Disorders Products, Services and Solutions 5.1.4 Valeant Pharmaceutical International Treatment for Syndromes of Dementia and Movement Disorders Revenue (US$ Million) & (2016-2021) 5.1.5 Valeant Pharmaceutical International Recent Developments 5.2 AstraZeneca GmbH 5.2.1 AstraZeneca GmbH Profile 5.2.2 AstraZeneca GmbH Main Business 5.2.3 AstraZeneca GmbH Treatment for Syndromes of Dementia and Movement Disorders Products, Services and Solutions 5.2.4 AstraZeneca GmbH Treatment for Syndromes of Dementia and Movement Disorders Revenue (US$ Million) & (2016-2021) 5.2.5 AstraZeneca GmbH Recent Developments 5.3 F. Hoffmann-La Roche 5.3.1 F. Hoffmann-La Roche Profile 5.3.2 F. Hoffmann-La Roche Main Business 5.3.3 F. Hoffmann-La Roche Treatment for Syndromes of Dementia and Movement Disorders Products, Services and Solutions 5.3.4 F. Hoffmann-La Roche Treatment for Syndromes of Dementia and Movement Disorders Revenue (US$ Million) & (2016-2021) 5.3.5 Abbott Laboratories Recent Developments 5.4 Abbott Laboratories 5.4.1 Abbott Laboratories Profile 5.4.2 Abbott Laboratories Main Business 5.4.3 Abbott Laboratories Treatment for Syndromes of Dementia and Movement Disorders Products, Services and Solutions 5.4.4 Abbott Laboratories Treatment for Syndromes of Dementia and Movement Disorders Revenue (US$ Million) & (2016-2021) 5.4.5 Abbott Laboratories Recent Developments 5.5 Merck 5.5.1 Merck Profile 5.5.2 Merck Main Business 5.5.3 Merck Treatment for Syndromes of Dementia and Movement Disorders Products, Services and Solutions 5.5.4 Merck Treatment for Syndromes of Dementia and Movement Disorders Revenue (US$ Million) & (2016-2021) 5.5.5 Merck Recent Developments 5.6 Sanofi 5.6.1 Sanofi Profile 5.6.2 Sanofi Main Business 5.6.3 Sanofi Treatment for Syndromes of Dementia and Movement Disorders Products, Services and Solutions 5.6.4 Sanofi Treatment for Syndromes of Dementia and Movement Disorders Revenue (US$ Million) & (2016-2021) 5.6.5 Sanofi Recent Developments 5.7 Novartis 5.7.1 Novartis Profile 5.7.2 Novartis Main Business 5.7.3 Novartis Treatment for Syndromes of Dementia and Movement Disorders Products, Services and Solutions 5.7.4 Novartis Treatment for Syndromes of Dementia and Movement Disorders Revenue (US$ Million) & (2016-2021) 5.7.5 Novartis Recent Developments 5.8 Bristol-Myers Squibb 5.8.1 Bristol-Myers Squibb Profile 5.8.2 Bristol-Myers Squibb Main Business 5.8.3 Bristol-Myers Squibb Treatment for Syndromes of Dementia and Movement Disorders Products, Services and Solutions 5.8.4 Bristol-Myers Squibb Treatment for Syndromes of Dementia and Movement Disorders Revenue (US$ Million) & (2016-2021) 5.8.5 Bristol-Myers Squibb Recent Developments 5.9 Baxter International 5.9.1 Baxter International Profile 5.9.2 Baxter International Main Business 5.9.3 Baxter International Treatment for Syndromes of Dementia and Movement Disorders Products, Services and Solutions 5.9.4 Baxter International Treatment for Syndromes of Dementia and Movement Disorders Revenue (US$ Million) & (2016-2021) 5.9.5 Baxter International Recent Developments 5.10 Pfizer 5.10.1 Pfizer Profile 5.10.2 Pfizer Main Business 5.10.3 Pfizer Treatment for Syndromes of Dementia and Movement Disorders Products, Services and Solutions 5.10.4 Pfizer Treatment for Syndromes of Dementia and Movement Disorders Revenue (US$ Million) & (2016-2021) 5.10.5 Pfizer Recent Developments 6 North America 6.1 North America Treatment for Syndromes of Dementia and Movement Disorders Market Size by Country (2016-2027) 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Treatment for Syndromes of Dementia and Movement Disorders Market Size by Country (2016-2027) 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Treatment for Syndromes of Dementia and Movement Disorders Market Size by Region (2016-2027) 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Treatment for Syndromes of Dementia and Movement Disorders Market Size by Country (2016-2027) 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Treatment for Syndromes of Dementia and Movement Disorders Market Size by Country (2016-2027) 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Treatment for Syndromes of Dementia and Movement Disorders Market Dynamics 11.1 Treatment for Syndromes of Dementia and Movement Disorders Industry Trends 11.2 Treatment for Syndromes of Dementia and Movement Disorders Market Drivers 11.3 Treatment for Syndromes of Dementia and Movement Disorders Market Challenges 11.4 Treatment for Syndromes of Dementia and Movement Disorders Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Treatment for Syndromes of Dementia and Movement Disorders Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027 Table 2. Global Treatment for Syndromes of Dementia and Movement Disorders Market Size by Region (2016-2021) & (US$ Million) Table 3. Global Treatment for Syndromes of Dementia and Movement Disorders Market Size Share by Region (2016-2021) Table 4. Global Treatment for Syndromes of Dementia and Movement Disorders Forecasted Market Size by Region (2022-2027) & (US$ Million) Table 5. Global Treatment for Syndromes of Dementia and Movement Disorders Forecasted Market Size Share by Region (2022-2027) Table 6. Global Treatment for Syndromes of Dementia and Movement Disorders Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027 Table 7. Global Treatment for Syndromes of Dementia and Movement Disorders Market Size by Type (2016-2021) & (US$ Million) Table 8. Global Treatment for Syndromes of Dementia and Movement Disorders Revenue Market Share by Type (2016-2021) Table 9. Global Treatment for Syndromes of Dementia and Movement Disorders Forecasted Market Size by Type (2022-2027) & (US$ Million) Table 10. Global Treatment for Syndromes of Dementia and Movement Disorders Revenue Market Share by Type (2022-2027) Table 11. Global Treatment for Syndromes of Dementia and Movement Disorders Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027 Table 12. Global Treatment for Syndromes of Dementia and Movement Disorders Market Size by Application (2016-2021) & (US$ Million) Table 13. Global Treatment for Syndromes of Dementia and Movement Disorders Revenue Market Share by Application (2016-2021) Table 14. Global Treatment for Syndromes of Dementia and Movement Disorders Forecasted Market Size by Application (2022-2027) & (US$ Million) Table 15. Global Treatment for Syndromes of Dementia and Movement Disorders Revenue Market Share by Application (2022-2027) Table 16. Global Treatment for Syndromes of Dementia and Movement Disorders Revenue (US$ Million) by Players (2016-2021) Table 17. Global Treatment for Syndromes of Dementia and Movement Disorders Revenue Market Share by Players (2016-2021) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Treatment for Syndromes of Dementia and Movement Disorders as of 2020) Table 19. Date of Key Manufacturers Enter into Treatment for Syndromes of Dementia and Movement Disorders Market Table 20. Global Treatment for Syndromes of Dementia and Movement Disorders Top Players Headquarters and Area Served Table 21. Treatment for Syndromes of Dementia and Movement Disorders Product Solution and Service Table 22. Global Treatment for Syndromes of Dementia and Movement Disorders Players Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Valeant Pharmaceutical International Basic Information List Table 25. Valeant Pharmaceutical International Description and Business Overview Table 26. Valeant Pharmaceutical International Treatment for Syndromes of Dementia and Movement Disorders Products, Services and Solutions Table 27. Revenue (US$ Million) in Treatment for Syndromes of Dementia and Movement Disorders Business of Valeant Pharmaceutical International (2016-2021) Table 28. Valeant Pharmaceutical International Recent Developments Table 29. AstraZeneca GmbH Basic Information List Table 30. AstraZeneca GmbH Description and Business Overview Table 31. AstraZeneca GmbH Treatment for Syndromes of Dementia and Movement Disorders Products, Services and Solutions Table 32. Revenue (US$ Million) in Treatment for Syndromes of Dementia and Movement Disorders Business of AstraZeneca GmbH (2016-2021) Table 33. AstraZeneca GmbH Recent Developments Table 34. F. Hoffmann-La Roche Basic Information List Table 35. F. Hoffmann-La Roche Description and Business Overview Table 36. F. Hoffmann-La Roche Treatment for Syndromes of Dementia and Movement Disorders Products, Services and Solutions Table 37. Revenue (US$ Million) in Treatment for Syndromes of Dementia and Movement Disorders Business of F. Hoffmann-La Roche (2016-2021) Table 38. F. Hoffmann-La Roche Recent Developments Table 39. Abbott Laboratories Basic Information List Table 40. Abbott Laboratories Description and Business Overview Table 41. Abbott Laboratories Treatment for Syndromes of Dementia and Movement Disorders Products, Services and Solutions Table 42. Revenue (US$ Million) in Treatment for Syndromes of Dementia and Movement Disorders Business of Abbott Laboratories (2016-2021) Table 43. Abbott Laboratories Recent Developments Table 44. Merck Basic Information List Table 45. Merck Description and Business Overview Table 46. Merck Treatment for Syndromes of Dementia and Movement Disorders Products, Services and Solutions Table 47. Revenue (US$ Million) in Treatment for Syndromes of Dementia and Movement Disorders Business of Merck (2016-2021) Table 48. Merck Recent Developments Table 49. Sanofi Basic Information List Table 50. Sanofi Description and Business Overview Table 51. Sanofi Treatment for Syndromes of Dementia and Movement Disorders Products, Services and Solutions Table 52. Revenue (US$ Million) in Treatment for Syndromes of Dementia and Movement Disorders Business of Sanofi (2016-2021) Table 53. Sanofi Recent Developments Table 54. Novartis Basic Information List Table 55. Novartis Description and Business Overview Table 56. Novartis Treatment for Syndromes of Dementia and Movement Disorders Products, Services and Solutions Table 57. Revenue (US$ Million) in Treatment for Syndromes of Dementia and Movement Disorders Business of Novartis (2016-2021) Table 58. Novartis Recent Developments Table 59. Bristol-Myers Squibb Basic Information List Table 60. Bristol-Myers Squibb Description and Business Overview Table 61. Bristol-Myers Squibb Treatment for Syndromes of Dementia and Movement Disorders Products, Services and Solutions Table 62. Revenue (US$ Million) in Treatment for Syndromes of Dementia and Movement Disorders Business of Bristol-Myers Squibb (2016-2021) Table 63. Bristol-Myers Squibb Recent Developments Table 64. Baxter International Basic Information List Table 65. Baxter International Description and Business Overview Table 66. Baxter International Treatment for Syndromes of Dementia and Movement Disorders Products, Services and Solutions Table 67. Revenue (US$ Million) in Treatment for Syndromes of Dementia and Movement Disorders Business of Baxter International (2016-2021) Table 68. Baxter International Recent Developments Table 69. Pfizer Basic Information List Table 70. Pfizer Description and Business Overview Table 71. Pfizer Treatment for Syndromes of Dementia and Movement Disorders Products, Services and Solutions Table 72. Revenue (US$ Million) in Treatment for Syndromes of Dementia and Movement Disorders Business of Pfizer (2016-2021) Table 73. Pfizer Recent Developments Table 74. North America Treatment for Syndromes of Dementia and Movement Disorders Market Size by Country (2016-2021) & (US$ Million) Table 75. North America Treatment for Syndromes of Dementia and Movement Disorders Market Size by Country (2022-2027) & (US$ Million) Table 76. Europe Treatment for Syndromes of Dementia and Movement Disorders Market Size by Country (2016-2021) & (US$ Million) Table 77. Europe Treatment for Syndromes of Dementia and Movement Disorders Market Size by Country (2022-2027) & (US$ Million) Table 78. Asia-Pacific Treatment for Syndromes of Dementia and Movement Disorders Market Size by Region (2016-2021) & (US$ Million) Table 79. Asia-Pacific Treatment for Syndromes of Dementia and Movement Disorders Market Size by Region (2022-2027) & (US$ Million) Table 80. Asia-Pacific Treatment for Syndromes of Dementia and Movement Disorders Market Share by Region (2016-2021) Table 81. Asia-Pacific Treatment for Syndromes of Dementia and Movement Disorders Market Share by Region (2022-2027) Table 82. Latin America Treatment for Syndromes of Dementia and Movement Disorders Market Size by Country (2016-2021) & (US$ Million) Table 83. Latin America Treatment for Syndromes of Dementia and Movement Disorders Market Size by Country (2022-2027) & (US$ Million) Table 84. Middle East & Africa Treatment for Syndromes of Dementia and Movement Disorders Market Size by Players (2016-2021) & (US$ Million) Table 85. Middle East & Africa Treatment for Syndromes of Dementia and Movement Disorders Market Size by Country (2022-2027) & (US$ Million) Table 86. Treatment for Syndromes of Dementia and Movement Disorders Market Trends Table 87. Treatment for Syndromes of Dementia and Movement Disorders Market Drivers Table 88. Treatment for Syndromes of Dementia and Movement Disorders Market Challenges Table 89. Treatment for Syndromes of Dementia and Movement Disorders Market Restraints Table 90. Research Programs/Design for This Report Table 91. Key Data Information from Secondary Sources Table 92. Key Data Information from Primary Sources List of Figures Figure 1. Global Treatment for Syndromes of Dementia and Movement Disorders Market Size Year-over-Year 2016-2027 & (US$ Million) Figure 2. Global Treatment for Syndromes of Dementia and Movement Disorders Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 3. Global Treatment for Syndromes of Dementia and Movement Disorders Market Share by Regions: 2021 VS 2027 Figure 4. Global Treatment for Syndromes of Dementia and Movement Disorders Forecasted Market Size Share by Region (2022-2027) Figure 5. North America Treatment for Syndromes of Dementia and Movement Disorders Market Size (US$ Million) Growth Rate (2016-2027) Figure 6. Europe Treatment for Syndromes of Dementia and Movement Disorders Market Size (US$ Million) and Growth Rate (2016-2027) Figure 7. Asia-Pacific Treatment for Syndromes of Dementia and Movement Disorders Market Size (US$ Million) and Growth Rate (2016-2027) Figure 8. Latin America Treatment for Syndromes of Dementia and Movement Disorders Market Size (US$ Million) and Growth Rate (2016-2027) Figure 9. Middle East & Africa Treatment for Syndromes of Dementia and Movement Disorders Market Size (US$ Million) and Growth Rate (2016-2027) Figure 10. Global Treatment for Syndromes of Dementia and Movement Disorders Market Size Share by Type in 2021 & 2027 Figure 11. Movement Disorders Market Size (US$ Million) YoY Growth (2016-2027) Figure 12. Progressive Dementia Market Size (US$ Million) YoY Growth (2016-2027) Figure 13. Progressive Dementia with Neurological Abnormality (PDNA) Market Size (US$ Million) YoY Growth (2016-2027) Figure 14. Global Treatment for Syndromes of Dementia and Movement Disorders Market Size Share by Application in 2021 & 2027 Figure 15. Below 70 Years Market Size (US$ Million) YoY Growth (2016-2027) Figure 16. Above 70 Years Market Size (US$ Million) YoY Growth (2016-2027) Figure 17. Treatment for Syndromes of Dementia and Movement Disorders Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 18. Global Top 5 and Top 10 Players Treatment for Syndromes of Dementia and Movement Disorders Market Share in 2020 Figure 19. North America Treatment for Syndromes of Dementia and Movement Disorders Market Share by Country (2016-2027) Figure 20. United States Treatment for Syndromes of Dementia and Movement Disorders Market Size (2016-2027) & (US$ Million) Figure 21. Canada Treatment for Syndromes of Dementia and Movement Disorders Market Size (2016-2027) & (US$ Million) Figure 22. Germany Treatment for Syndromes of Dementia and Movement Disorders Market Size (2016-2027) & (US$ Million) Figure 23. France Treatment for Syndromes of Dementia and Movement Disorders Market Size (2016-2027) & (US$ Million) Figure 24. U.K. Treatment for Syndromes of Dementia and Movement Disorders Market Size (2016-2027) & (US$ Million) Figure 25. Italy Treatment for Syndromes of Dementia and Movement Disorders Market Size (2016-2027) & (US$ Million) Figure 26. Russia Treatment for Syndromes of Dementia and Movement Disorders Market Size (2016-2027) & (US$ Million) Figure 27. Nordic Treatment for Syndromes of Dementia and Movement Disorders Market Size (2016-2027) & (US$ Million) Figure 28. Rest of Europe Treatment for Syndromes of Dementia and Movement Disorders Market Size (2016-2027) & (US$ Million) Figure 29. Asia-Pacific Treatment for Syndromes of Dementia and Movement Disorders Market Share by Region (2016-2027) Figure 30. China Treatment for Syndromes of Dementia and Movement Disorders Market Size (2016-2027) & (US$ Million) Figure 31. Japan Treatment for Syndromes of Dementia and Movement Disorders Market Size (2016-2027) & (US$ Million) Figure 32. South Korea Treatment for Syndromes of Dementia and Movement Disorders Market Size (2016-2027) & (US$ Million) Figure 33. Southeast Asia Treatment for Syndromes of Dementia and Movement Disorders Market Size (2016-2027) & (US$ Million) Figure 34. India Treatment for Syndromes of Dementia and Movement Disorders Market Size (2016-2027) & (US$ Million) Figure 35. Australia Treatment for Syndromes of Dementia and Movement Disorders Market Size (2016-2027) & (US$ Million) Figure 36. Rest of Asia-Pacific Treatment for Syndromes of Dementia and Movement Disorders Market Size (2016-2027) & (US$ Million) Figure 37. Latin America Treatment for Syndromes of Dementia and Movement Disorders Market Share by Country (2016-2027) Figure 38. Mexico Treatment for Syndromes of Dementia and Movement Disorders Market Size (2016-2027) & (US$ Million) Figure 39. Brazil Treatment for Syndromes of Dementia and Movement Disorders Market Size (2016-2027) & (US$ Million) Figure 40. Rest of Latin America Treatment for Syndromes of Dementia and Movement Disorders Market Size (2016-2027) & (US$ Million) Figure 41. Middle East & Africa Treatment for Syndromes of Dementia and Movement Disorders Market Share by Country (2016-2027) Figure 42. Turkey Treatment for Syndromes of Dementia and Movement Disorders Market Size (2016-2027) & (US$ Million) Figure 43. Saudi Arabia Treatment for Syndromes of Dementia and Movement Disorders Market Size (2016-2027) & (US$ Million) Figure 44. UAE Treatment for Syndromes of Dementia and Movement Disorders Market Size (2016-2027) & (US$ Million) Figure 45. Rest of Middle East & Africa Treatment for Syndromes of Dementia and Movement Disorders Market Size (2016-2027) & (US$ Million) Figure 46. Bottom-up and Top-down Approaches for This Report Figure 47. Data Triangulation

Valeant Pharmaceutical International AstraZeneca GmbH F. Hoffmann-La Roche Abbott Laboratories Merck Sanofi Novartis Bristol-Myers Squibb Baxter International Pfizer